The differential between Herbal and Modern Medicines
History of Mr. P, who is a Khmer traditional healer. Since he was young, he...
Pfizer to supply up to 6 million COVID pill courses for lower-income countries
The treatments will be provided to The Globalower-income and will allow 132 countries to receive...
FDA warns AstraZeneca’s Evusheld loses potency against new omicron subvariant
For COVID-19, antibody drugs in the pandemic world, it’s been living in the fast lane....
WHO has advised against the use of two antibody therapies against COVID
New guidance from the World Health Organization (WHO) strongly advises against using the antibody therapies Sotrovimab and Casirivimab-Imdevimab to treat…
Covid-19 Rebound after two different anti-retroviral drug treatments
Three types of COVID-19 rebound outcomes include COVID-19 infections, COVID-19 related symptoms, and hospitalizations.
What is Paxlovid?
Paxlovid three-pill antiviral regimen taken daily for five days. The drug, made by Pfizer, is prescribed to people who catch…
Paxlovid vs. Molnupiravir for COVID-19
Paxlovid and molnupiravir are used to treat mild to moderate COVID-19. These COVID-19 pills are only recommended for people with…
Adverse effects of COVID-19 medication Molnupiravir
The most crucial concern of Molnupiravir is adverse effects on pregnant and breastfeeding women, based...
Molnupiravir is not recommended for COVID-19 vaccinated patients
According to U.S NIH, the COVID-19 medication Molnupiravir is likely to be less favorable in...
COVID-19 pill taken orally will be commercial at under US$25 per treatment course for the treatment
The Medicines Patent Pool (MPP) announced today that it has signed agreements with 35 companies...
Start taking Medicine as soon as Possible if Diagnosed without worry
Beginning at the end of April 2022, a new round of COVID 19 epidemic broke out in Taiwan
Evusheld medication proves to be effective against Omicron BA.2 BA.4 and BA.5 variants
John L.Perez, AstraZeneca, said, “Evusheld is an important option to help protect an immunocompromised patient who is unable to respond…